Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Namdong-gu
Clinical trial register · South Korea

Clinical Trials in Namdong-gu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3427 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:17 UTC
3427
Studies in scope
all four open statuses
1884
Recruiting now
open to new participants
516
Lead sponsors
across recruiting studies
Top sites
Seoul 2883 Daegu 557 Seongnam-si 491 Busan 472 Goyang-si 403
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul2883 Daegu557 Seongnam-si491 Busan472 Goyang-si403 Incheon350 Suwon340 Daejeon215 Gyeonggi-do211 Seongnam208 Gwangju206 Cheongju-si189 Yangsan124 Bucheon-si111 Jeonju93 Wŏnju92 Hwasun85 Ulsan80 Ansan-si61 Jinju56 Goyang52 Anyang-si52 Chuncheon49 Pusan42 Hwasun-gun41 Ansan40 Changwon39 Guri-si39 Junggu37 Yongin-si36 Cheonan36 Jeollanam-do33 Namdong-gu33 Uijeongbu-si29 Gwangmyeong27 Cheonan-si27 Gangneung25 Anyang25 Seogu24 Deagu23 Jeju City21 Seongnam-si, Gyeonggi-do21 Hwaseong-si19 Gangnam-gu15 Seongnam-si Gyeonggi-do14 GangnamGu14 SeodaemunGu14 Ilsan14 Soeul14 Yongin13 Dongjak-gu13 Jongno-gu12 Gangwon-do12 SongpaGu12 Iksan12 Songpa-gu12 Sejong11 Goyang-si Gyeonggi-do11 Songpagu11 Changwon-si11 SeochoGu11 Suwon Kyunggi-do10 Donggu10 Haeundae-gu10 Bundang Gu10 Chungju9 Gyeongsan-si8 Seongbuk-Gu8 Seodaemun-gu8 Chungcheongbuk-do7 Multiple Locations7 Gyeongsangnam-do7 Seocho7 Hwasun Gun6 Jeollanam6 Gyeongsang6 Hwasun-Gun6 Dalseo-gu6 Cheongju Chungbuk6 Jongno -Gu5 Cheonju5 Songpa-dong5 Suwon Gyeonggi-do5 Gangnam-Gu5 Bupyeong-gu5 Seocho-Gu5 Jeonnam5 Haeundae4 Dongnam-gu, Cheonan-si4 Suncheon4 Cheongju Chungcheongbuk-do4 Namdong4 Goyang-si, Gyeonggi-do4 Wonju-si, Gangwon-do4 Yŏngin4 IlsandongGu GoyangSi4 Seodaemun-Gu4 Buk-gu3 Dongdaemun-gu3 Gangseo-gu3 Seongdong-gu3 Jungbuk3 Dongjak Gu3 Songpa-Gu3 Sinchon-dong3 BukGu3 Seocho-gu3 Dongjak3 Guro-gu3 Bupyeong-Gu3 BundangGu SeongnamSi3 Gangnam3 Ganggu3 Taegu3 Jongno-Gu3 Kwangju3 Many Locations3 Inchon3 Yeongdeungpo-gu3 Chilgok2 Buk Gu2 Bucheon Kyunggi-Do2 Yongsan-Ku Seoul2 Nam-Gu2 Jeollabuk-do2 Iksan-si2 Namdong-Gu2 Gimpo-si2 Siheung2 Hwaseong2 Seodaemun2 Dong-gu Ulsan2 Andong2 Hwasungun2 Kangwon-do2 Ansan-si, Gyeonggi-do2 Bundang-Gu, Seongnam-Si2 Seoungnam-si2 HwasunGun2 Ilsandong-gu2 Hwasun-gun, Jeollanam-do2 Gangneung-si2 Buk-Gu2 NamdongGu2 Bukgu2 Seongam2 Yongsan-gu2 Dong-gu2 Bucheonsi Weonmigu2 Chungcheongnam-do2 Yangcheon2 Seongnam Gyeonggi2 Jeju-do2 Changwon-Si2 Yangsan-si, Gyeongsangnam-do2 Daejoen2 PaldalGu SuwonSi2 Seongdong2 Jeongnam2 Bucheon-si, Gyeonggi-do2 서구1 Inceon1 Ilsandong1 JinJoo1 Pyeongchon1 Hwasun-eup1 Hwaseong-si, Gyeonggi-do1 Sungnam1 Jemulpo-gu1 Korea1 Namyangju1 Yangju1 Sejong-si1 Jongno1 Busan-si1 Bucheon-si Kyunggi-do 145841 Gangnam Gu1 Jinju-si Gyeongsangnam-do1 Naju1 Daehak-ro, Jongno-gu1 Ilsandong-gu, Goyang-si1 Gyeongsangbuk-do1 Bundang-gu1 Gwangju Gwangyeoksi1 Hwasun-eup, Hwasun-gun1 Kangwondo1 Gangdong-gu1 Yangpyeong1 Hwasun-Eup1 Dalseo1 Seocho -Gu1 Gumi1 Beon-gil Bundang-gu1 Gwangjin-Gu1 SeongbukGu1 HaeundaeGu1 Cheonansi1 Dalseogu1 DanwonGu AnsanSi1 Dongan-Gu, Anyang-Si1 Jungni I Gu1 Kyungki-do1 BusanjinGu1 Songpa1 Gyeongnam1 Jungnam1 Kyonggi-do1 Jongno-gu, Seoul1 Seocho-gu, Seoul1 Jeju Special1 Irwon-dong1 Yongsan1 Taejŏn1 Buchon1 Namwon1 Gandong-gu1 Hwasan1 Pusan Kwangyokshi1 Jeonlabuk-do1 Gunpo1 Cheonan Si1 Yangsang1 Anyang-si, Gyeonggi-do1 Bucheon, Gyeonggi-do1 Icheon1 Anam1 Seongnamsi Bundang1 Sinchŏn-dong1 Dongan1 Cheonan-Si1 Cheongiu1 Pyeongtaek-si1 Gyeongju1 Chungcheongbuk Do1 Jeonam1 Gwangjin-gu1 Pohang1 Gyeongin1 Sangam-dong1 Dongjakgu1 Suweonsi Paldalgu1 Heungdeok-Gu1 Hanam1 Seowon-Gu1 Eunpyeong-gu1 Gwangjingu1 Bundang-gu, Seongnam-si1 Ilsandong-Gu, Goyang-Si1 Kangwon Do1 Iksan Si1 Dong-gu, Ulsan1 Tongdaemun-Gu1 Geumam1 Hwasŏng1 Ilsan-gu1 Ansan-si Gyenggi-do1 Suwon-si Gyeonggi-do1 Suwon-si, Gyeonggi-do1
All 258 locations
Target enrolment
to

Trials with a site in Namdong-gu

35 of 3427 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Namdong-gu, Bucheon-si, Goyang-si, Suwon, Busan, Haeundae-gu, Seoul, Dong-gu, Ulsan
2026-12-16
Not yet open
Eli Lilly and Company
Phase 3
2,115
Ansan-si, Busan, Guri-si, Gwangju, Gyeongsan-si, Junggu, Namdong-gu, Seogu
2026-12
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies, Amyloid
Eli Lilly and Company
Phase 2
350
Gangnam-gu, Incheon, Namdong-gu, Seoul
2026-05-20
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Namdong-gu, Seoul
2026-05-06
Recruiting
Eli Lilly and Company
Phase 3
1,980
Namdong-gu, Seogu, Seongnam, Seoul, Yangsan
2026-02-06
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Goyang-si, Junggu, Namdong-gu, Seongnam, Seoul
2025-12-12
Recruiting
Eli Lilly and Company
Phase 3
7,140
Busan, Daegu, Guri-si, Gwangju, Namdong-gu, Seongnam, Seoul, Ulsan
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
1,100
Anyang-si, Busan, Cheongju-si, Guri-si, Incheon, Junggu, Namdong-gu, Seogu
2025-10-16
Recruiting
Eli Lilly and Company
Phase 3
1,100
Busan, Cheongju-si, Guri-si, Junggu, Namdong-gu, Seogu, Seongnam, Seoul
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Daegu, Gwangju, Namdong-gu, Seongnam, Seoul, Suwon, Ulsan
2025-09-02
Recruiting
AstraZeneca
Phase 2
278
Cheongju-si, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-08-07
Recruiting
Pfizer
Phase 3
300
Namdong-gu, Gwangju, Seoul
2025-07-14
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Gwangju, Gyeonggi-do, Incheon, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-07-02
Recruiting
Pfizer
Phase 3
2,330
Donggu, Namdong-gu, Wŏnju, Gwangju, Ansan-si, Suwon, Dongjak-gu, Gangnam-gu
2024-12-08
Active, closed
Eli Lilly and Company
Phase 3
1,400
Busan, Cheongju-si, Gangnam-gu, Gangseo-gu, Gwangju, Incheon, Jeju City, Namdong-gu
2024-10-24
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Cheongju-si, Namdong-gu, Hwasun, Goyang-si, Seongnam-si, Yangsan, Busan, Seoul
2024-10-07
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
NCT06535607Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
AstraZeneca
Phase 2
257
Incheon, Namdong-gu, Seoul
2024-08-22
Recruiting
AstraZeneca
Phase 3
582
Goyang-si, Namdong-gu, Seoul, Suwon
2024-04-29
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bucheon-si, Daegu, Daejeon, Dongjak-gu, Gwangju, Namdong-gu, Seongnam, Seoul
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
3,127
Namdong-gu, Ansan-si, Anyang-si, Suwon, Busan, Seoul, Seogu
2023-06-05
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Namdong-gu, Seoul
2023-03-16
Active, closed
Pfizer
Phase 3
624
Namdong-gu, Goyang-si, Seongnam, Suwon, Seoul
2023-03-03
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
Eli Lilly and Company
Phase 3
1,500
Busan, Guri-si, Gwangju, Incheon, Junggu, Namdong-gu, Seongnam, Seongnam-si
2022-10-10
Active, closed
Pfizer
Phase 3
854
Namdong-gu, Hwasun Gun, Seongnam, Busan, Seoul, Daegu, Junggu
2022-03-25
Active, closed
Eli Lilly and Company
Phase 3
874
Cheonan-si, Namdong-gu, Suwon, Daegu, Busan, Seoul
2021-10-04
Active, closed
Pfizer
Phase 3
77
Namdong-gu, Goyang-si, Seongnam, Seoul
2021-09-29
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Namdong-gu, Seocho-Gu, Seoul, Busan
2021-09-23
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Cheonan-si, Jemulpo-gu, Cheongju-si, Gangwon-do, Gyeonggi-do, Namdong-Gu, Seongbuk-Gu, Seongnam
2021-08-27
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Namdong-gu, Seoul, Busan
2021-04-08
Active, closed
Eli Lilly and Company
Phase 3
5,637
Cheongju-si, Cheonan-si, Incheon, Namdong-gu, Goyang-si, Seongnam, Busan, Haeundae-gu
2017-07-12
Active, closed
Eli Lilly and Company
Phase 3
669
Cheongju-si, Incheon, Namdong-gu, Seongnam, Seoul, Ulsan
2014-07-22
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/namdong-gu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,427 studies in total at the last sync on 20 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Namdong-gu.

How many clinical trials are recruiting in Namdong-gu?

18 of the 35 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Namdong-gu), 35 studies
PhaseStudiesRecruitingShare
Phase 3291382.9%
Phase 26517.1%

Most active sponsors

Lead sponsors with the most studies (Namdong-gu)
Lead sponsorStudiesRecruiting
Eli Lilly and Company157
Pfizer52
AstraZeneca33
Hoffmann-La Roche32
Loxo Oncology, Inc.30
Bristol-Myers Squibb21
Jazz Pharmaceuticals11
Merck Sharp & Dohme LLC10
Mirati Therapeutics Inc.11
Regeneron Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.